Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo

Citation
Jd. Reeves et al., Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo, J VIROLOGY, 73(9), 1999, pp. 7795-7804
Citations number
90
Categorie Soggetti
Microbiology
Journal title
JOURNAL OF VIROLOGY
ISSN journal
0022538X → ACNP
Volume
73
Issue
9
Year of publication
1999
Pages
7795 - 7804
Database
ISI
SICI code
0022-538X(199909)73:9<7795:PHIVT2>2.0.ZU;2-X
Abstract
Cell surface receptors exploited by human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) for infection are major determinants of tropism. HIV-1 usually requires two receptors to infect cells. Gp120 on HI V-1 virions binds CD4 on the cell surface, triggering conformational rearra ngements that create or expose a binding site for a seven-transmembrane (7T M) coreceptor. Although HIV-2 and SIV strains also use CD4, several laborat ory-adapted HIV-2 strains infect cells without CD4, via an interaction with the coreceptor CXCR4. Moreover, the envelope glycoproteins of SIV of macaq ues (SIVMAC) can bind to and initiate infection of CD4(-) cells via CCR5. H ere, we show that most primary HIV-2 isolates can infect either CCR5(+) or CXCR4(+) cells without CD4. The efficiency of CD4-independent infection by HIV-2 was comparable to that of SIV, but markedly higher than that of HIV-1 . CD4(-)independent HIV-2 strains that could use both CCR5 and CXCR4 to inf ect CD4(+) cells were only able to use one of these receptors in the absenc e of CD4. Our observations therefore indicate (i) that HIV-2 and SIV envelo pe glycoproteins form a distinct conformation that enables contact with a 7 TM receptor without CD4, and (ii) the use of CD4 enables a wider range of 7 TM receptors to be exploited for infection and may assist adaptation or swi tching to new coreceptors in vivo. Primary CD4(-) fetal astrocyte cultures expressed CXCR4 and supported replication by the T-cell-line-adapted ROD/B strain. Productive infection by primary X4 strains was only triggered upon treatment of virus with soluble CD4. Thus, many primary HIV-2 strains infec t CCR5(+) or CXCR4(+) cell lines without CD4 in vitro. CD4(-) cells that ex press these coreceptors in vivo, however, may still resist HIV-2 entry due to insufficient coreceptor concentration on the cell surface to trigger fus ion or their expression in a conformation nonfunctional as a coreceptor. Ou r study, however, emphasizes that primary HIV-2 strains carry the potential to infect CD4(-) cells expressing CCR5 or CXCR4 in vivo.